Plain-English translation of NCT05913622 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When your heart fails suddenly and severely, doctors may use a machine called VA ECMO (a heart-lung bypass system) to take over your heart's work and keep you alive. This trial is testing whether adding an intra-aortic balloon pump (IABP)—a small balloon device that sits in your main artery—helps your heart recover better when used together with the ECMO machine. The goal is to find out if this additional device helps more patients survive and successfully come off the machine.
ECMO machines save lives, but many patients struggle to come off them successfully, and some don't survive. Doctors think that the ECMO machine itself can put extra stress on your heart, which might cause dangerous fluid buildup in the lungs or blood clots. Adding this unloading device might prevent these complications and help more patients recover.
You likely qualify if…
You likely don't qualify if…
If you qualify and agree to join, you will be randomly assigned to receive either ECMO support alone or ECMO support with the additional balloon pump device. You will be cared for in the hospital's intensive care unit, where doctors will monitor your heart function closely and work toward safely weaning you off the machines as your heart recovers. The study also includes detailed tracking of your medical care and outcomes to help doctors understand which approach works better.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Belgium
Netherlands